Kanzawa, Taichi
Hirai, Toshihito
Fukuda, Hironori
Katsumata, Haruki
Ishii, Rumi
Ikemiyagi, Masako
Ishii, Yasuyuki
Saiga, Kan
Okumi, Masayoshi
Tanabe, Kazunari
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP15K19864)
Article History
Received: 14 September 2018
Accepted: 9 January 2019
First Online: 13 February 2019
Compliance with ethical standards
:
: Y. Ishii is the executive chairman of REGiMMUNE Corp. The other authors declare that they have no conflict of interest.
: Animal studies were approved by the Tokyo Women’s Medical University internal committee on the use and care of laboratory animals approved all experiments (Reference ID: AE16-105-2). All animals received human care according to the criteria outlined in the “Guide for the Care and Use of Laboratory Animals” prepared by the National Academy of Sciences and published by the National Institutes of Health (NIH publication 86-23, revised 1985) as well as the current version of the Japanese law “Act on Welfare and Management of Animals” (revised 2013).
: For this type of study formal informed consent is not required.